Long-Term Olanzapine Treatment in Children With Autism

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

July 31, 2011

Study Completion Date

October 31, 2011

Conditions
Autism
Interventions
DRUG

Olanzapine

Olanzapine tablets, dosed once or twice per day, dosage 2.5 to 20 mg per day

Trial Locations (1)

19124

Drexel University College of Medicine at Friends Hospital, Philadelphia

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Drexel University

OTHER

NCT00183404 - Long-Term Olanzapine Treatment in Children With Autism | Biotech Hunter | Biotech Hunter